PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance-Reference-Cited by-同舟云学术

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance

Published:2011-10 Issue:10 Volume:100 Page:4090-4110
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Ring Barbara J.,Chien Jenny Y.,Adkison Kimberly K.,Jones Hannah M.,Rowland Malcolm,Jones Rhys Do,Yates James W.T.,Ku M. Sherry,Gibson Christopher R.,He Handan,Vuppugalla Ragini,Marathe Punit,Fischer Volker,Dutta Sandeep,Sinha Vikash K.,Björnsson Thorir,Lavé Thierry,Poulin Patrick

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference28 articles.

1. PhRMA CPCDC initiative on predictive models of human pharmacokinetics. 1. Goals, properties of the PhRMA dataset and comparison with literature datasets;Poulin;J Pharm Sci,2011

2. Prediction of clearance in humans from in vitro human liver microsomes and allometric scaling. A comparative study of the two approaches;Mahmood;Drug Metab Drug Interact,2002

3. Prediction of human drug clearance from animal data: Application of the rule of exponent and fu corrected intercept method (FCIM);Mahmood;J Pharm Sci,2006

4. Interspecies pharmacokinetic scaling, allometry, physiological time and the ground plan of pharmacokinetics;Boxenbaum;J Pharmacokin Biopharm,1982

5. Estimation of human drug clearance using multiexponential techniques;Goteti;J Clin Pharmacol,2008

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Pyrazolo[1,5-a]pyridine Derivatives as Potent and Selective PI3Kγ/δ Inhibitors;Journal of Medicinal Chemistry;2024-08-20

2. Studies on pharmacokinetic properties and intestinal absorption mechanism of sanguinarine chloride: in vivo and in situ;Toxicology Mechanisms and Methods;2024-08

3. Prediction of human serum concentration–time profiles of therapeutic monoclonal antibodies using common marmosets ( Callithrix jacchus ): initial assessment with canakinumab, adalimumab, and bevacizumab;Xenobiotica;2024-07-26

4. In vitro and in vivo studies on the metabolism and pharmacokinetics of the selective gut microbial β-glucuronidase targeting compound Inh 1;Xenobiotica;2024-06-12

5. EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials;European Journal of Nuclear Medicine and Molecular Imaging;2024-02-17